KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $406,300 | +15.7% | 303,209 | +54.6% | 0.00% | – |
| Q2 2023 | $351,032 | -79.8% | 196,107 | -56.1% | 0.00% | – |
| Q1 2023 | $1,739,157 | -5.7% | 447,084 | -17.5% | 0.00% | – |
| Q4 2022 | $1,843,456 | -56.8% | 542,193 | -30.7% | 0.00% | -100.0% |
| Q3 2022 | $4,269,000 | +23.1% | 782,017 | +1.7% | 0.00% | – |
| Q2 2022 | $3,467,000 | -58.5% | 768,636 | -32.1% | 0.00% | -100.0% |
| Q1 2022 | $8,349,000 | -30.0% | 1,132,829 | -38.9% | 0.00% | – |
| Q4 2021 | $11,920,000 | +133.3% | 1,853,452 | +111.1% | 0.00% | – |
| Q3 2021 | $5,109,000 | -35.1% | 877,893 | +15.1% | 0.00% | – |
| Q2 2021 | $7,874,000 | +50.2% | 762,905 | +53.1% | 0.00% | -100.0% |
| Q1 2021 | $5,243,000 | -78.0% | 498,458 | -67.6% | 0.00% | -50.0% |
| Q4 2020 | $23,802,000 | +301.2% | 1,537,646 | +278.5% | 0.00% | +100.0% |
| Q3 2020 | $5,932,000 | -59.7% | 406,289 | -47.7% | 0.00% | -75.0% |
| Q2 2020 | $14,720,000 | +7.4% | 777,174 | +8.9% | 0.00% | -20.0% |
| Q1 2020 | $13,709,000 | +19.3% | 713,656 | +19.1% | 0.01% | +66.7% |
| Q4 2019 | $11,491,000 | +159.6% | 599,400 | +30.2% | 0.00% | +200.0% |
| Q3 2019 | $4,427,000 | +9.3% | 460,327 | -31.9% | 0.00% | – |
| Q2 2019 | $4,052,000 | -15.5% | 676,380 | -17.7% | 0.00% | -100.0% |
| Q1 2019 | $4,798,000 | +298.8% | 821,649 | +540.2% | 0.00% | – |
| Q4 2018 | $1,203,000 | -10.2% | 128,346 | +63.3% | 0.00% | – |
| Q3 2018 | $1,339,000 | +94.6% | 78,600 | +94.1% | 0.00% | – |
| Q2 2018 | $688,000 | -66.7% | 40,500 | -73.7% | 0.00% | -100.0% |
| Q1 2018 | $2,066,000 | +40.6% | 153,900 | +0.6% | 0.00% | – |
| Q4 2017 | $1,469,000 | +29.9% | 152,990 | +48.5% | 0.00% | – |
| Q3 2017 | $1,131,000 | +4.3% | 103,014 | -13.9% | 0.00% | – |
| Q2 2017 | $1,084,000 | -33.5% | 119,709 | -5.6% | 0.00% | – |
| Q1 2017 | $1,629,000 | +37.1% | 126,783 | +0.3% | 0.00% | – |
| Q4 2016 | $1,188,000 | +211.8% | 126,392 | +222.0% | 0.00% | – |
| Q3 2016 | $381,000 | +0.3% | 39,249 | -30.7% | 0.00% | – |
| Q2 2016 | $380,000 | -52.7% | 56,600 | -37.1% | 0.00% | – |
| Q1 2016 | $803,000 | -23.3% | 90,019 | +14.0% | 0.00% | – |
| Q4 2015 | $1,047,000 | -59.7% | 78,979 | -68.0% | 0.00% | – |
| Q3 2015 | $2,596,000 | -24.2% | 246,599 | +95.9% | 0.00% | -100.0% |
| Q2 2015 | $3,424,000 | -27.1% | 125,853 | -18.0% | 0.00% | -50.0% |
| Q1 2015 | $4,700,000 | +52.3% | 153,552 | +86.3% | 0.00% | +100.0% |
| Q4 2014 | $3,086,000 | -12.6% | 82,425 | -18.4% | 0.00% | -50.0% |
| Q3 2014 | $3,529,000 | – | 101,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |